3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Diseases
1
Neoplasms by Site
1
Intestinal Neoplasms
1
Intestinal Diseases
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Digestive System Neoplasms
1
Digestive System Diseases
1
Colorectal Neoplasms
1
Interventions
Oxaliplatin
3
Magnetic Resonance Spectroscopy
3
Exercise Test
2
Cyclophosphamide
2
Capecitabine
2
trifluridine tipiracil drug combination
1
penpulimab
1
pembrolizumab
1
lutetium Lu 177 dotatate
1
huachansu
1
guadecitabine
1
copper dotatate CU-64
1
XELOX
1
Ursodeoxycholic Acid
1
Surveys and Questionnaires
1
Restraint, Physical
1
Physical Examination
1
Oviposition
1
Observation
1
Lutetium-177
1
Lutetium
1
Irinotecan
1
Indocyanine Green
1
Hyperthermic Intraperitoneal Chemotherapy
1
Health Information Exchange
1
Gemcitabine
1
Gastroscopy
1
Fluorouracil
1
Fluorescein
1
Endoscopy, Digestive System
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Diseases
×
Oviposition
×
Clear all
NCT01269567
2026-05-14
GRECCAR 5
University Hospital, Bordeaux
Phase 3
Completed
494 enrolled